Stocks to Watch: HCLTech, Tata Technologies, Rallis India, RailTel and more

1 / 10HCLTech | The company downgraded its margin guidance for the full fiscal year as the IT major announced its Q1 results for the period ended 30 June 2025 on Monday, 14 July. The company lowered its EBIT margin outlook to 17-18% from the earlier 18-19%, reflecting margin pressures experienced during the quarter. In Q1 FY26, EBIT margins contracted by 160 basis points quarter-on-quarter to 16.3%, down from 17.9% in the previous quarter.2 / 10Tata Technologies | For the June quarter, Tata Technologies reported a 10% drop in its net profit to ₹170 crore. During the March quarter, the company had reported a net profit of ₹189 crore. A CNBC-TV18 poll had pegged the figure to be ₹155 crore. In US Dollar terms, the company reported revenue of $145.3 million, which is 2.1% lower in comparison to the March quarter. In constant currency terms, revenue growth was a negative 4.6%, which is better than the CNBC-TV18 poll of a 6.5% decline.3 / 10Rallis India | Agri solutions provider, reported a 98% year-on-year (YoY) zoom in net profit at ₹95 crore for the first quarter that ended June 30, 2025. In the corresponding quarter of the previous fiscal, Rallis India posted a net profit of ₹48 crore. The company’s revenue from operations surged 22% to ₹957 crore as against ₹783 crore in the corresponding period of the preceding fiscal.4 / 10RailTel Corporation | State-owned company said it has received a work order worth ₹264 crore (including tax) from East Central Railway for the implementation of the Kavach system, the indigenous Train Collision Avoidance System (TCAS). The scope of the contract includes the provision of Kavach on 607 route kilometres of low-density railway track under the jurisdiction of East Central Railway. The project is scheduled for completion by July 14, 2027.5 / 10Tejas Networks | The company reported a consolidated net loss of ₹193.9 crore in Q1 FY26 from a net profit of ₹77.5 crore in the year-ago period. The loss was attributed to delayed purchase orders and shipment clearances, particularly relating to the BSNL 4G project. Revenue plunged 87% year-on-year to ₹211 crore from ₹1,563 crore in Q1 FY25, and dropped 89% sequentially.6 / 10RVNL | The state-owned company said it has received a Letter of Award (LOA) from Delhi Metro Rail Corporation Limited (DMRC) for a project under the Delhi MRTS Phase-IV. The awarded Contract involves the design and construction of a 7.298 km viaduct, including the construction of platforms for seven stations — Pushp Vihar, Saket District Court, Pushpa Bhawan, Chirag Delhi, GK-1, Andrews Ganj, and Lajpat Nagar.7 / 10Power Mech Projects | Infrastructure services firm said it has secured two operation and maintenance (O&M) contracts totalling ₹551.35 crore (excluding taxes, duties, levies, cess, and GST). The first order, worth ₹498.39 crore, has been awarded by SJVN Thermal (P) Ltd for commissioning support and comprehensive O&M of the coal-based supercritical Buxar thermal power project (2 x 660 MW) located at Chausa in Buxar district, Bihar. The execution period for this contract is 39 months.8 / 10AstraZeneca Pharma | The company said it has received permission from the Central Drugs Standard Control Organisation (CDSCO), Directorate General of Health Services, Government of India, to import Durvalumab Solution for Infusion (brand name: Imfinzi) for an additional indication in the country. The approval allows the company to market Imfinzi 120 mg/2.4 ml and 500 mg/10 ml in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by Imfinzi monotherapy as adjuvant treatment post-radical cystectomy.9 / 10Sun Pharmaceutical | The company announced the US launch of LEQSELVI (deuruxolitinib) 8 mg tablets for the treatment of adults with severe alopecia areata. The drug is now available nationwide to healthcare providers and eligible patients. The launch follows a recently announced settlement and license agreement with Incyte Corporation, resolving ongoing litigation in the United States District Court for the District of New Jersey. The companies will now seek dismissal of the case before the court.10 / 10LIC | R Doraiswamy officially assumed charge as the new Chief Executive Officer and Managing Director (CEO & MD) of Life Insurance Corporation of India. Doraiswamy’s tenure will run for three years from the date of taking charge, or until he reaches the age of 62 on August 28, 2028, or until further orders, whichever is earlier.

Source link